Airsculpt TechnologiesPublic market company profile.Web2Healthcare companies and projects
Explore healthcare companies and projects across pharmaceuticals, biotechnology, medical equipment, care services and health-data infrastructure. Browse public profiles and the evaluations available on Orbitrum, then discover the experts behind the research.
Projects in Healthcare
Stage
All stages
4,357 projects
Airsculpt TechnologiesPublic market company profile.Web2
Ajanta Pharma LtdAjanta Pharma Limited, together with its subsidiaries, a pharmaceutical formulation company engages in the development, manufacture, and marketing of specialty pharmaceutical finished dosages. The company offers chronic and acute therapies; branded generic products; and a range of dosage forms, including tablets, capsules, eye drops, dry powder suspension, injectables, inhalers, ointments, creams, and liquids. It also serves various therapeutic areas comprising cardiology, dermatology, ophthalmology, gynaecology, nephrology, and pain management. The company operates in India, Africa, Asia, the United States, and internationally. Ajanta Pharma Limited was founded in 1973 and is headquartered in Mumbai, India.Web2
AkandaPublic market company profile.Web2
AkditalAkdital S.A operates in the healthcare sector in Morocco. The company offers its services in the areas of surgical, interventional medicine, critical and intensive care, maternity care, oncology, and diagnostic services. It operates private hospitals, multidisciplinary, and clinics and oncology centers. The company was founded in 2011 and is headquartered in Casablanca, Morocco.Web2
Akebia TherPublic market company profile.Web2
AkesoAkeso, Inc., a biopharmaceutical company, engages in the research, development, manufacture, and commercialization of antibody drugs worldwide. The company develops AK104, a PD-1/CTLA-4 bi-specific antibody to treat cervical cancer, gastric cancer, lung cancer, and liver cancer; and AK112, a PD-1/VEGF bi-specific antibody to treat lung cancer, biliary tract cancer, head and neck squamous cell carcinoma, breast cancer, colorectal cancer, and pancreatic cancer. It is also developing AK117, a CD47 monoclonal antibody to treat myelodysplastic syndrome, acute myeloid leukemia, and recurrent or refractory classical Hodgkin lymphoma; AK109, a PD-1 monoclonal antibody to treat G/GEJ patients; penpulimab, a PD-1 for the treatment of recurrent or metastatic nasopharyngeal carcinoma (NPC); and tagitanlimab, a PD-L1 for treating recurrent or metastatic NPC. In addition, the company develops AK102, a PCSK9 monoclonal antibody to treat hypercholesterolemia and mixed hyperlipidemia; AK101, an IL-12/IL-23 monoclonal antibody to treat moderate-to-severe psoriasis and ulcerative colitis; AK111, an IL-17 monoclonal antibody to treat moderate-to-severe psoriasis and ankylosing spondylitis; and AK120, an IL-4R monoclonal antibody to treat moderate-to-severe atopic dermatitis. Further, its preclinical product includes AK120 to treat moderate-to-severe atopic dermatitis. The company was founded in 2012 and is headquartered in Zhongshan, the People’s Republic of China.Web2
Aktis OncologyAktis Oncology, Inc., a clinical-stage oncology company, engages in the research, development, and commercialization of targeted radiopharmaceuticals to treat various solid tumor cancers. The company’s lead product candidate includes [225Ac]Ac-AKY-1189, a miniprotein radioconjugate platform which is in ongoing Phase 1b clinical trial for the treatment of Nectin-4 expressing solid tumors, including locally advanced or metastatic urothelial cancer, breast cancer, NSCLC, colorectal cancer and cervical cancer; and [225Ac]Ac-AKY-2519 to deliver 225Ac to B7-H3 (CD276) expressing tumors, including prostate, lung and other solid tumors. It has license and collaboration agreements with Protein Innovation, Inc., TRIUMF Innovations, Inc., and Eli Lilly. The company was formerly known as HotKnot Therapeutics, Inc. and changed its name to Aktis Oncology, Inc. in April 2020. Aktis Oncology, Inc. was incorporated in 2020 and is headquartered in Boston, Massachusetts.Web2Learn how to assess projects in this field with Orbitrum Academy.
About this sector
Healthcare includes both medical businesses and projects supporting how health information or research is managed. Its application sub-sectors cover pharmaceuticals, biotechnology and medical research, healthcare equipment and providers, medical records, research transparency, supply-chain transparency and patient-data privacy.
How to compare projects
A drug developer, a device supplier, a care provider and a health-data project have different activities. Use the sub-sector to establish that context, then read the actual evaluation rather than assuming a score describes every aspect of the business. This collection is for project research, not for choosing a medical treatment.
Projects follow the categories assigned in the Orbitrum application. This collection supports research and discovery; it is not an investment ranking.
Industry definitions
Healthcare Equipment & Supplies (1,090)
Suppliers of healthcare equipment and related supplies.
Pharmaceuticals (1,515)
Companies classified specifically in pharmaceuticals.
Biotechnology & Medical Research (1,179)
Companies and projects focused on biotechnology or medical research.
Healthcare Providers & Services (573)
Organizations providing healthcare or related services.
Questions to guide your research
- What product, service or health-data function does the project provide?
- Which development or operating milestones are documented in the profile and research?
- What evidence and limitations does the author discuss?
Questions about this sector
Does this sector include biotechnology and medical devices?
Yes. The current application classification includes biotechnology and medical research, pharmaceuticals, healthcare equipment and supplies, and healthcare services and medical devices. The list below reflects the categories available in Orbitrum.
How can I find healthcare experts?
Open the authors attached to published evaluations or analysis of these projects. Their profiles show the work available on Orbitrum; a project category alone does not establish an author's medical qualifications.
